Ashok Agarwal | |
---|---|
![]() | |
Born | Lucknow, India |
Nationality | American |
Alma mater | 1965–68:Middle School, Mahanagar Boys High School (Lucknow, India) 1969–70:High School, Central Hindu School (Varanasi, India) 1971–72:Pre-University Course, Central Hindu School (Varanasi, India) 1972–75:BSc (Honors in Zoology), Banaras Hindu University (Varanasi, India) 1975–77:MSc, Specialization in Reproductive Physiology, Banaras Hindu University (Varanasi, India) 1977–83:PhD in Zoology, Specialization in Mammalian Reproductive Biology, Banaras Hindu University (Varanasi, India) 1984–86:Post-Doctoral Fellow (Rockefeller Foundation Fellowship in Reproductive Biology), Harvard Medical School (Boston, United States) |
Known for | Research Work in Human Reproductive Medicine |
Scientific career | |
Fields | Medical Scientist, Researcher, Andrologist/Reproductive Biologist |
Institutions | Cleveland Clinic |
Doctoral advisor | C. J. Dominic, PhD (BHU, Cantab), FNA, Professor, Dept. of Zoology, Banaras Hindu University (Varanasi, India) |
Other academic advisors | Anita P. Hoffer, PhD, Ed.D., Associate Professor and Director of Research in Urology, Harvard Medical School, (Boston, United States) (Post-Doctoral Advisor) |
Website | American Center for Reproductive Medicine |
Ashok Agarwal is the Director of the Andrology Center, and also the Director of Research at the American Center for Reproductive Medicine at Cleveland Clinic, Cleveland, USA. [1] He is Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, USA. Ashok is a Senior Staff in the Cleveland Clinic's Glickman Urological and Kidney Institute. [1] He has published extensive translational research in human infertility and assisted reproduction.
Ashok obtained his BSc (Honors) in 1975, MSc in 1977 and PhD in 1983 at Banaras Hindu University, Varanasi (India), [2] under the guidance of Late C. J. Dominic, PhD, FNA. [3] He did his post-doctoral research on a Rockefeller Foundation Fellowship at the Division of Urology, Harvard Medical School and the Brigham and Women's Hospital [2] in Boston, Massachusetts (1984–1986), under the guidance of Anita P. Hoffer, PhD, Ed.D.
After his post-doctoral training at Harvard Medical School, Boston, Ashok worked as the Director of the Andrology Laboratory and Sperm Bank at the Newton-Wellesley Hospital, Boston (Medical Director: Robert A. Newton, M.D., F.A.C.S.) between 1986 and 1988. [2] He was then appointed as the Director of Male Infertility Research and as an instructor in surgery and later an Assistant Professor of Urology at Harvard Medical School (Director of Urologic Research: Kevin R. Loughlin, M.D.) between 1988 and 1992. [4] Aside from his teaching responsibilities, Ashok worked as the Coordinator of Andrology Testing in the Reproductive Endocrinology Laboratory in the Brigham and Women's Hospital (Medical Director: George L. Mutter, M.D.). [2] Ashok was appointed in 1993 by the Cleveland Clinic Foundation, Ohio, as the Head of the Clinical Andrology Center, [4] which over the years under his leadership, has become a center of excellence for the diagnosis of male infertility and for fertility preservation of men with oncological conditions in the United States.
Ashok is a board certified Clinical Laboratory Director (HCLD) in Andrology by the American Board of Bioanalysis [5] [6] and an Inspector for the College of American Pathologists "Reproductive Laboratory Program" for accreditation of Andrology and In Vitro Fertilization (IVF) Laboratories. [7] He has served as the Chairman of Board of the American College of Embryology from 2009 to 2012. [8]
He is the Director of the highly successful Summer Internship Course in Reproductive Medicine. [9] In the last 13 years, over 320 pre-med and medical students from across the United States and overseas have graduated from this highly successful annual program. [10]
Ashok is active in basic and clinical research [11] and his laboratory [12] has trained more than 525 basic scientists and clinical researchers from over 55 countries. [13] His American Center for Reproductive Medicine has provided hands on training to 210 candidates in human assisted reproduction (Embryology and Andrology techniques) from 45 countries. [14]
By the number of citations, he is the most cited author of several medicaljournals such as Fertility and Sterility, Urology, Reproductive Biomedicine Online, Andrologia, Reproductive Biology and Endocrinology. [15] Ashok has been invited as a guest speaker to over 30 countries for important international meetings. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [ excessive citations ] He has directed more than a dozen Assisted Reproductive Technology (ART) and Andrology Laboratory Workshops [39] [40] and Symposia [41] [42] [43] [44] in recent years. He is a member of the International Advisory Committee on Male Infertility for the Society for Translational Medicine.
Ashok has published over 840 research articles and reviews in peer reviewed PubMed-indexed scientific journals. He has also authored over 225 book chapters in specialized medical books, and presented over 830 papers at both national and international scientific meetings. His Hirsch index (h-index) is 150 (Google Scholar) and 107 (Scopus), while his citation count is over 90,653 on Google Scholar. According to ResearchGate, Ashok has an RG Score of 54.37 on 2,193 publications (1245 articles, 54 books, 250 chapters, 486 conference papers). Ashok is ranked as the No. 1 Author in andrology/male Infertility and ART-related research, based on a Global Ranking of Authors Publishing in Andrology or Male Infertility report employing exhaustive searches on the Scopus database. [45] [46] Ashok is currently an editor of 42 medical text books or manuals related to male infertility, ART, fertility preservation, sperm chromatin damage and antioxidants. He is also the Guest Editor of 12 special journal issues and an ad hoc reviewer for over 50 scientific journals. [1]
Ashok serves on the Editorial Board of Asian Journal of Andrology, [47] Human Andrology, [48] Human Fertility, [49] International Brazilian Journal of Urology, [50] International Journal of Fertility & Sterility, [51] Reproductive BioMedicine Online, [52] Reproductive Biology & Endocrinology, [53] Translational Andrology and Urology, [54] The World Journal of Men's Health, [55] and International Journal of Molecular Sciences. [56]
Ashok is the recipient of over 100 research grants and is actively involved in laboratory and clinical studies looking at the efficacy of certain antioxidants in improving the fertility of male patients.
In the early years, Ashok and his team at ACRM studied the physiological levels of reactive oxygen species (ROS) and its relationship with sperm quality in healthy volunteers of unproven fertility and in infertile men. They went on to study the negative effects of oxidative stress generated during sperm processing and cryopreservation during ART procedures on semen quality. Ashok and his researchers looked into the cut-off values for ROS levels to distinguish between fertile and infertile men and the measurement of oxidative stress.
In the following decade, Ashok and his team at ACRM investigated the physiological and pathophysiological effects (both direct and indirect) of endogenous and exogenous ROS. Ashok and his researchers continued to examine normal range of ROS generation to distinguish between fertile and infertile men.
In the new millennium, Ashok and his team at ACRM examined the role of antioxidants (e.g. carnitines, vitamins C and E, pentoxifyline) as defense mechanisms to neutralize and prevent the over-production of ROS in relation to male infertility.
In the more recent years, Ashok has been working on the studies on molecular markers of oxidative stress, DNA integrity, effect of radio frequency radiation on fertility and fertility preservation in patients with cancer. His research focus currently is on the use of proteomics and bioinformatics tools in discovering the biological processes and pathways underlying OS-induced infertility.
A complete repository of Ashok's research publications (1991 – current) is available here. Ashok Agarwal's ORCID ID is https://orcid.org/0000-0003-0585-1026 and his Scopus Author ID is 7401480880. His ResearchGate profile is available here.
Infertility is the inability of a couple to reproduce by natural means. It is usually not the natural state of a healthy adult. Exceptions include children who have not undergone puberty, which is the body's start of reproductive capacity. It is also a normal state in women after menopause.
Andrology is a name for the medical specialty that deals with male health, particularly relating to the problems of the male reproductive system and urological problems that are unique to men. It is the parallel to gynecology, which deals with medical issues which are specific to female health, especially reproductive and urologic health.
Testicular atrophy is a medical condition in which one or both testicles diminish in size and may be accompanied by reduced testicular function. Testicular atrophy is not related to the temporary shrinkage of the surrounding scrotum, which might occur in response to cold temperature.
A varicocele is, in a man, an abnormal enlargement of the pampiniform venous plexus in the scrotum; in a woman, it is an abnormal painful swelling to the embryologically identical pampiniform venous plexus; it is more commonly called pelvic compression syndrome. In the male varicocele, this plexus of veins drains blood from the testicles back to the heart. The vessels originate in the abdomen and course down through the inguinal canal as part of the spermatic cord on their way to the testis. Varicoceles occur in around 15% to 20% of all men. The incidence of varicocele increase with age.
A spermatogonium is an undifferentiated male germ cell. Spermatogonia undergo spermatogenesis to form mature spermatozoa in the seminiferous tubules of the testicles.
Azoospermia is the medical condition of a man whose semen contains no sperm. It is associated with male infertility, but many forms are amenable to medical treatment. In humans, azoospermia affects about 1% of the male population and may be seen in up to 20% of male infertility situations in Canada.
The American Society for Reproductive Medicine (ASRM) is a nonprofit, multidisciplinary organization for advancement of the science and practice of reproductive medicine. The society has its headquarters in Washington, D.C., and its administrative office in Birmingham, Alabama. An associated special interest group, the Society for Assisted Reproductive Technology (SART), maintains a national registry for tracking IVF attempts and outcomes.
Male infertility refers to a sexually mature male's inability to impregnate a fertile female. In humans, it accounts for 40–50% of infertility. It affects approximately 7% of all men. Male infertility is commonly due to deficiencies in the semen, and semen quality is used as a surrogate measure of male fecundity. More recently, advance sperm analyses that examine intracellular sperm components are being developed.
Testicular sperm extraction (TESE) is a surgical procedure in which a small portion of tissue is removed from the testicle and any viable sperm cells from that tissue are extracted for use in further procedures, most commonly intracytoplasmic sperm injection (ICSI) as part of in vitro fertilisation (IVF). TESE is often recommended to patients who cannot produce sperm by ejaculation due to azoospermia.
Reproductive medicine is a branch of medicine concerning the male and female reproductive systems. It encompasses a variety of reproductive conditions, their prevention and assessment, as well as their subsequent treatment and prognosis.
Teratospermia or teratozoospermia is a condition characterized by the presence of sperm with abnormal morphology that affects fertility in males.
Reproductive surgery is surgery in the field of reproductive medicine. It can be used for contraception, e.g. in vasectomy, wherein the vasa deferentia of a male are severed, but is also used plentifully in assisted reproductive technology. Reproductive surgery is generally divided into three categories: surgery for infertility, in vitro fertilization, and fertility preservation.
Marc Goldstein is an American urologist who is the Matthew P. Hardy Distinguished Professor of Reproductive Medicine, and Urology at Weill Cornell Medical College; Surgeon-in-Chief, Male Reproductive Medicine and Surgery; and Director of the Center of Male Reproductive Medicine and Microsurgery at New York Presbyterian Hospital. He is Adjunct Senior Scientist with the Population Council's Center for Biomedical Research, located on the campus of Rockefeller University.
Antisperm antibodies (ASA) are antibodies produced against sperm antigens.
Robert John Aitken is an Anglo-Australian reproductive biologist, widely known for identifying oxidative stress as a significant contribution to infertility and its actions on human sperm function. He also made substantial contributions to clinical practice translation in male reproductive health, notably the development of new contraceptive vaccine.
The male infertility crisis is an increase in male infertility since the mid-1970s. The issue attracted media attention after a 2017 meta-analysis found that sperm counts in Western countries had declined by 52.4 percent between 1973 and 2011. The decline is particularly prevalent in Western countries such as New Zealand, Australia, Europe, and North America. A 2022 meta-analysis reported that this decline extends to non-Western countries, namely those in Asia, Africa, Central America, and South America. This meta-analysis also suggests that the decline in sperm counts may be accelerating.
Sarah Martins da SilvaFRCOG is a British gynaecologist and researcher specialising in male infertility. Martins da Silva is a Clinical Reader in reproductive medicine at the University of Dundee. She also works as an honorary consultant gynaecologist at Ninewells Hospital in Dundee, specialising in fertility problems and assisted conception. She was named one of the BBC's "100 Women of 2019" for her contribution to fertility science.
Sperm Chromatin Structure Assay (SCSA) is a diagnostic approach that detects sperm abnormality with a large extent of DNA fragmentation. First described by Evenson in 1980, the assay is a flow cytometric test that detects the vulnerability of sperm DNA to acid-induced denaturation DNA in situ. SCSA measures sperm DNA fragmentation attributed to intrinsic and extrinsic factors and reports the degree of fragmentation in terms of DNA Fragmentation Index (DFI). The use of SCSA expands from evaluation of male infertility and subfertility, toxicology studies and evaluation of quality of laboratory semen samples. Notably, SCSA outcompetes other convention sperm DNA fragmentation (sDF) assays such as TUNEL and COMET in terms of efficiency, objectivity, and repeatability.
Ranjith Ramasamy is a consultant urologist at Jumeirah American Clinic in Dubai, UAE, and the former Director of the Reproductive Urology Fellowship program at the University of Miami's Miller School of Medicine.
Larry I. Lipshultz is an American urologist, surgeon, researcher, and teacher. He currently serves as Professor of Urology, Lester and Sue Smith Endowed Chair in Reproductive Medicine, and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine, Houston, Texas.